CN104000208A - Soft deep sea fish oil capsule containing squalene - Google Patents
Soft deep sea fish oil capsule containing squalene Download PDFInfo
- Publication number
- CN104000208A CN104000208A CN201410221339.4A CN201410221339A CN104000208A CN 104000208 A CN104000208 A CN 104000208A CN 201410221339 A CN201410221339 A CN 201410221339A CN 104000208 A CN104000208 A CN 104000208A
- Authority
- CN
- China
- Prior art keywords
- fish oil
- sea fish
- squalene
- deep sea
- oil capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000021323 fish oil Nutrition 0.000 title claims abstract description 23
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 title claims abstract description 22
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 title claims abstract description 22
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 title claims abstract description 22
- 229940031439 squalene Drugs 0.000 title claims abstract description 22
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 title claims abstract description 22
- 239000002775 capsule Substances 0.000 title claims abstract description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 7
- 229940046009 vitamin E Drugs 0.000 claims abstract description 7
- 239000011709 vitamin E Substances 0.000 claims abstract description 7
- 239000007901 soft capsule Substances 0.000 claims description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 11
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 7
- 108010010803 Gelatin Proteins 0.000 abstract description 4
- 208000007536 Thrombosis Diseases 0.000 abstract description 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract description 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract description 4
- 229920000159 gelatin Polymers 0.000 abstract description 4
- 239000008273 gelatin Substances 0.000 abstract description 4
- 235000019322 gelatine Nutrition 0.000 abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 208000029078 coronary artery disease Diseases 0.000 abstract description 3
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 210000000056 organ Anatomy 0.000 abstract description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 3
- 241001465754 Metazoa Species 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract description 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 abstract description 2
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 abstract 3
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 3
- 230000036772 blood pressure Effects 0.000 abstract 1
- 235000019197 fats Nutrition 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a soft deep sea fish oil capsule containing squalene. The soft deep sea fish oil capsule comprises deep sea fish oil which serves as a main active ingredient and contains EPA (eicosapentaenoic acid) and DHA (docosahexenoic acid), squalene (squalene) and vitamin E, and water, glycerinum and edible animal gelatin which serve as main auxiliary materials. The soft deep sea fish oil capsule has the beneficial effects that omega-3 highly unsaturated fatty acid (EPA, DHA) and highly unsaturated hydrocarbon compound (squalene) are effectively combined together, so that the components further achieve a synergistic effect; the soft deep sea fish oil capsule has the effects of well reducing blood fat, dissolving thrombus, reducing blood pressure and preventing cardiovascular and cerebrovascular diseases such as coronary heart diseases, and has the functions of purifying the blood and recovering all damaged organs as soon as possible.
Description
(1) technical field
The present invention relates to a kind of fish oil soft capsule, especially a kind of deep-sea fish oil soft capsules that contains squalene, belongs to health food technology field.
(2) background technology
At present, along with improving constantly of living standard, people constantly increase the intake of higher fatty acid meat product, incident is the continuous rising of fat content in blood, and the diseases such as the arterial sclerosis causing thus, thrombus, coronary heart disease, affect and have endangered middle-aged and old Health and Living quality day by day.In order to prevent the generation of this type of disease, people start more edible fish oil series products, due to existing various fish oil series products ubiquities on market: active ingredient is simple, functional component content is low, functional component proportioning is unreasonable, cause that product function is single, the shortcoming of DeGrain, be difficult to play desirable prophylactic effect.
(3) summary of the invention
The present invention is in order to make up the deficiencies in the prior art, a kind of deep-sea fish oil soft capsules that contains squalene is provided, main active ingredient is: deep sea fish oil [contain EPA(eicosapentaenoic acid), DHA(DHA)], squalene (squalene), vitamin E, major auxiliary burden is water, glycerine and edible animal gelatin.
EPA in deep sea fish oil, DHA composition are a kind of special unrighted acids, and being is of value to the sanguimotor protection factor.EPA can assist to remove the cholesterol and the harden plaque that are attached on vascular wall, reduces Blood Cholesterol level, contributes to keep unobstructed blood to flow, and suppresses undesired blood aggegation, pre-preventing thrombosis generation, stops the generation of apoplexy or miocardial infarction.
Squalene has similar red blood cell and absorbs like that the function of oxygen, generate the oxidation MF59 of activation, be transported in body cell of termination and discharge oxygen with blood, therefore can obviously improve the anaerobic condition of body cell, activate physical function cell, strengthen the function of the each organ of health bringing about its decline due to cardiovascular and cerebrovascular disease.Effect that squalene purifies the blood in addition, after blood purification, a lot of pathologies that cause because of poor circulation, such as heart disease, hypertension, low blood pressure and apoplexy etc., can be prevented or be treated.
Vitamin E can protect highly unsaturated fatty acid (EPA, DHA) and squalene not oxidized, extend shelf life of products.
The invention has the beneficial effects as follows: this fish oil soft capsule effectively combines ω-3 highly unsaturated fatty acid (EPA, DHA) and height unsaturated hydrocarbons compounds (squalene), between composition, further act synergistically, there is the effect of the cardiovascular and cerebrovascular diseases such as better reducing blood lipid, thrombus, hypotensive and prevention coronary heart disease, and can in treatment, purify the blood, recover as early as possible the function of each damaged organ.
(4) detailed description of the invention
1, preparation content: by admixed together according to certain formula to raw material deep sea fish oil, squalene, vitamin E, stir, the percentage by weight of content functional component net content is EPA:25.2%, DHA:16.8%, squalene: 29%, vitamin E: 1%.
2, make capsule body material: taking edible gelatin, glycerine and pure water as utricule raw material, glycerine and pure water are proportionally injected in glue pot, and heating is stirred to 75 DEG C of left and right, then adds gelatin, continue to stir final vacuum deaeration in 20～30 minutes, make and obtain envelop materials.
3, the content preparing and capsule body are passed through to pelleting, moulding, wash ball, are dried, make finished product deep-sea fish oil soft capsules.
Claims (4)
1. a deep-sea fish oil soft capsules that contains squalene, is characterized in that: the percentage by weight of capsule 's content is: fish oil: 70%, squalene: 29%, vitamin E: 1%.
2. a kind of deep-sea fish oil soft capsules that contains squalene according to claim 1, is characterized in that: in fish oil, the mass percent of functional component EPA is: 36%, the mass percent of DHA is: 24%.
3. a kind of deep-sea fish oil soft capsules that contains squalene according to claim 2, is characterized in that: the mass percent of capsule 's content functional component is: EPA:25.2%, DHA: 16.8%, squalene: 29%, vitamin E: 1%.
4. a kind of deep-sea fish oil soft capsules that contains squalene according to claim 1, is characterized in that: described health products are soft capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410221339.4A CN104000208A (en) | 2014-05-25 | 2014-05-25 | Soft deep sea fish oil capsule containing squalene |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410221339.4A CN104000208A (en) | 2014-05-25 | 2014-05-25 | Soft deep sea fish oil capsule containing squalene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104000208A true CN104000208A (en) | 2014-08-27 |
Family
ID=51361332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410221339.4A Pending CN104000208A (en) | 2014-05-25 | 2014-05-25 | Soft deep sea fish oil capsule containing squalene |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104000208A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105030836A (en) * | 2015-06-24 | 2015-11-11 | 山东圣海保健品有限公司 | Soft capsule for improving memory and delaying aging |
| CN105030835A (en) * | 2015-06-24 | 2015-11-11 | 山东圣海保健品有限公司 | Soft capsule for improving memory |
| CN105395574A (en) * | 2015-12-29 | 2016-03-16 | 徐州市铜山区生命科学研究院 | Medicinal and edible compound squalene and fish oil soft capsule for preventing and treating cardiovascular and cerebtovascular disease |
| CN107183687A (en) * | 2017-05-22 | 2017-09-22 | 福建海唯美海洋生物科技有限公司 | It is a kind of can anti-aging, repair blood vessel and soften blood vessel health-preserving food |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11253112A (en) * | 1998-03-10 | 1999-09-21 | Nof Corp | Protein-free healthy food |
| CN1341421A (en) * | 2000-09-07 | 2002-03-27 | 哈尔滨仁皇药业有限公司 | Shaliwikang soft capsule |
| CN1376471A (en) * | 2002-03-22 | 2002-10-30 | 海南加华海产生物制药有限公司 | Soft capsule 'Shaganling' |
| CN101810336A (en) * | 2010-04-30 | 2010-08-25 | 广东仙乐制药有限公司 | Chewable soft capsules and method for preparing same |
-
2014
- 2014-05-25 CN CN201410221339.4A patent/CN104000208A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11253112A (en) * | 1998-03-10 | 1999-09-21 | Nof Corp | Protein-free healthy food |
| CN1341421A (en) * | 2000-09-07 | 2002-03-27 | 哈尔滨仁皇药业有限公司 | Shaliwikang soft capsule |
| CN1376471A (en) * | 2002-03-22 | 2002-10-30 | 海南加华海产生物制药有限公司 | Soft capsule 'Shaganling' |
| CN101810336A (en) * | 2010-04-30 | 2010-08-25 | 广东仙乐制药有限公司 | Chewable soft capsules and method for preparing same |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105030836A (en) * | 2015-06-24 | 2015-11-11 | 山东圣海保健品有限公司 | Soft capsule for improving memory and delaying aging |
| CN105030835A (en) * | 2015-06-24 | 2015-11-11 | 山东圣海保健品有限公司 | Soft capsule for improving memory |
| CN105395574A (en) * | 2015-12-29 | 2016-03-16 | 徐州市铜山区生命科学研究院 | Medicinal and edible compound squalene and fish oil soft capsule for preventing and treating cardiovascular and cerebtovascular disease |
| CN107183687A (en) * | 2017-05-22 | 2017-09-22 | 福建海唯美海洋生物科技有限公司 | It is a kind of can anti-aging, repair blood vessel and soften blood vessel health-preserving food |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104082751A (en) | Deep sea fish oil soft capsule containing astaxanthin | |
| CN109337939B (en) | Preparation method of polyunsaturated fatty acid structure lipid | |
| CN102942987B (en) | Method for extracting fish oil from head and internal organ of Scomber japonicus by using compound protease | |
| CN104000208A (en) | Soft deep sea fish oil capsule containing squalene | |
| CN101427816A (en) | Fishy smell removed polydiluted acid capsule | |
| CN103989179A (en) | Deep sea fish oil soft capsule containing ginkgo leaf extract | |
| CN104055123A (en) | Gamma-linolenic acid containing deep sea fish oil soft capsule | |
| CN103989181A (en) | Walnut oil-containing fish oil soft capsule | |
| CN104127857A (en) | Fish oil soft capsule and preparation method thereof | |
| CN103989180B (en) | Deep-sea fish oil soft capsules containing Salvia root P.E | |
| CN101194913A (en) | Natural seal oil compression biological preparation for treating hyperlipidemia and technique of preparing the same | |
| CN103989176B (en) | Deep-sea fish oil soft capsules containing kudzu root extract | |
| CN103734413B (en) | A kind of green alga tea and preparation method thereof | |
| CN103989185A (en) | Deep sea fish oil soft capsule containing coenzyme Q | |
| CN103989175A (en) | Deep sea fish oil soft capsule containing apocynum venetum extract | |
| CN103652924A (en) | Compound grape seed oil soft capsule and preparation method for compound grape seed oil soft capsule | |
| JP6892532B2 (en) | In vivo fatty acid content increasing agent | |
| CN104082752A (en) | Squalene containing seal oil soft capsules | |
| KR20110100788A (en) | Maturing method for abalone using the abalone broth and soybean paste composition | |
| CN103989178A (en) | Deep sea fish oil soft capsule containing ginkgo leaf oil | |
| CN104082741A (en) | Soft seal oil capsule containing astaxanthin | |
| CN106036562A (en) | Processing technology of dried loach | |
| CN104055117A (en) | Seal oil soft capsule containing arachidonic acid | |
| CN104432032A (en) | Health food capable of reducing blood fat | |
| CN104432335A (en) | Wild blueberry-black fungus-honey mixed juice drink and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140827 |